Rabbit COVID 19 Spike Coronavirus Polyclonal Antibody | anti-COVID-19 antibody

SARS-CoV-2 (COVID-19) Spike Antibody (HRP)

Cat. Num. AAA154811

• Reactivity: Virus; Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (100%)
• Applications: ELISA
• Purity: SARS-CoV-2 (COVID-19) Spike Antibody is affinity chromatography purified via peptide column.
• Synonyms: COVID 19 Spike Coronavirus; Polyclonal Antibody; SARS-CoV-2 (COVID-19) Spike Antibody (HRP); 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; SpikeSARS-CoV-2 (COVID-19) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Surface Glycoprotein; Spike protein; anti-COVID-19 antibody

• Host: Rabbit
• Reactivity: Virus; Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (100%)
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: SARS-CoV-2 (COVID-19) Spike Antibody is affinity chromatography purified via peptide column.
• Form/Format: Liquid; SARS-CoV-2 (COVID-19) Spike Antibody is supplied in PBS containing 0.02% sodium azide.
• Concentration: 1mg/mL (varies by lot)

• Applicable Applications for anti-COVID-19 antibody: ELISA (EIA)
• Immunogen: Anti-SARS-CoV-2 (COVID-19) Spike antibody (HRP) was raised against a peptide corresponding to 20 amino acids near the carboxy terminus of SARS-CoV-2 (COVID-19) Spike glycoprotein.; ; The immunogen is located within the last 50 amino acids of SARS-CoV-2 (COVID-19) Spike protein.
• Conjugation: HRP
• Protein GI#: 1791269090
• Isoform: SARS-CoV-2 (COVID-19) Spike has one isoform (1273aa).
• NCBI Organism: Wuhan seafood market pneumonia virus
• Preparation and Storage: SARS-CoV-2 (COVID-19) Spike antibody can be stored at 4 degree C for three months and -20 degree C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

ELISA (EIA)

(Figure 1 ELISA Validation Coating Antigen: immunogen peptide, 10ug/mL, incubate at 4 degree C overnight.Detection Antibodies: SARS-CoV-2 Spike antibody, dilution: 0.5-1000 ng/mL, incubate at RT for 1 hr. was detected by anti-rabbit HRP-conjugated secondary antibodies at 1:10,000, incubate at RT for 1 hr.)

Related Product Information for anti-COVID-19 antibody

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019-20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

Product Categories/Family for anti-COVID-19 antibody

Primary Antibody; Infectious Disease; COVID-19

References

Gorbalenya. bioRxiv: 2020.
Hui et al. Int J Infect Dis. 2020;91:264-266.
Belouzard et al. Viruses. 2012;4(6):1011-33.
Lee et al. J Virol. 2006;80(8):4079-87.
Wan et al. J Virol. 2020.
Wrapp et al. Science. 2020.
Nuovo GJ et al. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx. Ann Diagn Pathol. 2020; 48:151565. doi: 10.1016/j.anndiagpath.2020.151565. PMID: 32659620
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020; 220:1-13. doi: 10.1016/j.trsl.2020.04.007. PMID: 32299776
Ko, et al. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol. 2021 Jan;48(1):47-52. doi: 10.1111/cup.13866. Epub 2020 Oct 1.PMID: 32895985 
Magro, et al. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019. Hum Pathol. 2020 Dec;106:106-116. doi: 10.1016/j.humpath.2020.10.002. Epub 2020 Oct 12.PMID: 33058948
Magro, et al. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol. 2020 Jul 22;10.1111/bjd.19415. doi: 10.1111/bjd.19415PMID: 32779733
Mulvey, et al. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Ann Diagn Pathol. 2020 Jun;46:151530. doi: 10.1016/j.anndiagpath.2020.151530. Epub 2020 Apr 25.PMID: 32387855
Nuovo, et al. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Ann Diagn Pathol. 2020 Oct;48:151600. doi: 10.1016/j.anndiagpath.2020.151600. Epub 2020 Aug 13.PMID: 32805515
Singh, et al. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nat Microbiol. 2021 Jan;6(1):73-86. doi: 10.1038/s41564-020-00841-4. Epub 2020 Dec 18PMID: 33340034

NCBI and Uniprot Product Information

• NCBI GeneID: 43740568
• NCBI Official Full Name: Spike glycoprotein